An oncology focused, kinase targeted pipeline

We leverage our deep kinase expertise to discover, optimize and develop a sustainable pipeline of small molecule kinase inhibitors. Learn about our candidates for cancer and other diseases with unmet medical need.

More About Our Pipeline» More About Our Clinical Trials»

Partnering with Ambit makes a difference

Our existing collaborations provide a strong endorsement of the benefits offered by our expertise in kinase drug discovery. Click below to learn more about the many ways to collaborate with Ambit.

More About Our Partnering Strategy»More About Our Partnerships»

Upcoming Conferences & Events

  • 03.06.2012 - Boston, MA – 32nd Annual Cowen and Company Health Care Conference

Ambit Corporate Presentation

  • To view the Ambit company presentation at the 14th Annual BIO CEO & Investor conference in New York, NY on February 13, 2012, please click here.